virus
take
advantag
cellular
endocyt
pathway
enter
host
cell
intern
viru
particl
move
dynam
network
endocyt
vesicl
undergo
gradual
sort
complex
matur
event
endosom
matur
turn
trigger
conform
chang
dissoci
event
incom
virus
ultim
lead
deliveri
viral
genom
associ
protein
cytoplasm
gener
nonenvelop
howev
endocyt
pathway
ibv
hijack
unclear
earli
step
entri
process
ibv
target
cell
initi
engag
glycoprotein
receptor
use
sever
cell
line
permiss
ibv
beaudett
strain
report
ibv
virion
attach
lipid
raft
cell
surfac
effici
entri
ibv
cell
requir
presenc
intact
lipid
raft
also
address
ibv
entri
pathway
systemat
perturb
inhibitor
antibodi
endocytot
pathway
inhibitor
amilorid
nystatin
chlorpromazin
cpz
purchas
selleck
usa
actin
monomersequest
drug
cytochalasin
cytod
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
actin
polymerstabil
jasplakinolid
ja
purchas
thermo
fisher
scientif
usa
endosom
acidif
inhibitor
nh
cl
cholesterol
deplet
drug
cholesterolwat
solubl
purchas
sigmaaldrich
usa
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
cell
viabil
assay
ph
assess
viabil
drugtreat
cell
measur
use
cell
prolifer
cytotox
assay
kit
beyotim
haimen
china
accord
manufactur
instruct
cell
seed
plate
treat
indic
drug
ad
well
incub
h
absorb
nm
monitor
refer
wavelength
set
nm
viabil
cell
calcul
comparison
untreat
cell
assess
effect
nh
cl
ph
chang
acid
intracellular
vesicl
vero
cell
treat
increas
concentr
nh
cl
min
follow
stain
mgml
acridin
orang
serum
free
medium
min
cell
wash
twice
pb
stain
dapi
dihydrochlorid
roch
imag
taken
zeiss
axio
observ
fluoresc
microscop
membran
flotat
analysi
cell
incub
ibv
moi
h
mockinfect
cell
lyse
ice
min
ml
tne
lysi
buffer
triton
supplement
complet
proteas
inhibitor
cocktail
cell
lysat
centrifug
min
remov
cell
debri
nuclei
supernat
collect
mix
ml
tne
buffer
sucros
place
bottom
ultracentrifug
tube
overlaid
ml
ml
sucros
tne
buffer
lysat
ultracentrifug
h
rotor
beckman
centrifug
fraction
ml
collect
top
bottom
tube
subject
follow
western
blot
use
antibodi
antin
protein
anti
protein
rnasefre
ethanol
dissolv
rnasefre
water
level
intern
viral
genom
rna
grna
neg
genom
rna
grna
determin
real
time
rtpcr
use
primer
target
ibv
genom
briefli
total
rna
use
perform
revers
transcript
use
expand
revers
transcriptas
roch
usa
oligodtspecif
primer
equal
volum
cdna
pcramplifi
use
sybr
green
pcr
master
kit
dongsheng
biotech
guangdong
china
genom
copi
number
normal
level
use
compar
cycl
threshold
valu
determin
parallel
experi
data
analyz
rel
control
assay
perform
three
replic
primer
sequenc
use
rtpcr
shown
tabl
wash
pbst
thrice
blot
develop
enhanc
chemiluminesc
ecl
detect
system
ge
healthcar
life
scienc
usa
expos
chemiluminesc
gel
imag
system
tanon
shanghai
china
membran
strip
strip
buffer
mm
sd
mm
triscl
ph
min
reprob
antibodi
immunostain
cell
seed
chamber
slide
infect
moi
indic
time
point
cell
fix
authorfund
right
reserv
reus
allow
without
permiss
dilut
pb
bsa
follow
pb
wash
cell
incub
dapi
min
rins
pb
final
specimen
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
cellular
cdna
clone
vector
restrict
enzym
hind
tabl
densitometri
intens
correspond
band
quantifi
use
imagej
program
nih
ibv
entri
lipid
raftassoci
lipid
raft
cholesterolenrich
microdomain
mani
cellular
protein
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mention
receptor
ibv
entri
controversi
wherea
work
state
heparan
sulfat
select
attach
factor
ibv
beaudett
strain
anoth
report
conclud
sialic
acid
receptor
test
hypothesi
vero
cell
incub
ibv
h
lipid
although
previou
studi
demonstr
ibv
strain
beaudett
entri
sensit
drug
treatment
neutral
low
ph
endosom
bhk
cell
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
also
shown
differ
cell
type
differ
abil
allow
viral
entri
thu
dissect
ibv
entri
pathway
necessari
verifi
whether
low
ph
depend
entri
ibv
cell
type
specif
end
increas
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
sever
phdepend
endocyt
pathway
use
variou
virus
includ
cme
cavm
macropinocytosi
clathrincaveolinindepend
endocytosi
identifi
endocyt
pathway
employ
ibv
pharmacolog
inhibit
sirnamedi
deplet
overexpress
domin
neg
constitut
activ
protein
carri
block
strengthen
respect
endocyt
pathway
first
investig
effect
ibv
entri
divers
pharmacolog
drug
treatment
well
known
inhibit
cme
cavm
macropinocytosi
vero
cell
expos
increas
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
dose
depend
manner
amilorid
nystatin
pretreat
effect
fig
thu
result
reveal
ibv
enter
cell
via
cme
via
macropinocytosi
whether
cavm
involv
ibv
endocytosi
may
cell
type
depend
controversi
explor
involv
cavm
ibv
entri
util
cell
lack
function
caveola
perform
releas
progeni
viru
particl
also
determin
tcid
result
fig
show
express
significantli
reduc
progeni
viru
product
around
signific
effect
compar
gfp
express
cell
result
suggest
ibv
entri
depend
function
vero
cell
fig
c
howev
silenc
express
signific
effect
ibv
grna
intern
fig
moreov
although
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
deplet
inhibit
vsv
g
express
fig
ibv
n
protein
express
unchang
knock
fig
data
confirm
although
ibv
entri
depend
cme
requir
furthermor
knock
accompani
signific
reduct
amount
incom
ibv
grna
ibv
protein
express
fig
collect
result
indic
function
requir
ibv
entri
ibv
infect
fig
data
reveal
ibv
could
infect
cell
express
inhibit
vsv
infect
fig
collect
data
indic
major
ibv
virion
deliv
earli
endosom
cme
follow
transfer
late
endosom
knock
carri
confirm
conclus
cell
transfect
follow
ibv
infect
knock
effect
rab
ibv
n
protein
express
examin
western
blot
fig
show
express
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
infect
fig
altogeth
data
confirm
intern
cme
earli
late
endosom
requir
ibv
transport
impli
ibv
membran
undergo
fusion
late
endosomelysosom
membran
hpi
hpi
also
perform
fusion
experi
use
well
studi
vsv
label
control
report
fuse
earli
endosom
shown
supplementari
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
red
spot
observ
minpi
overlap
yellow
spot
white
arrow
second
panel
without
overlap
minpi
green
spot
detect
coloc
pink
spot
white
arrow
third
fourth
panel
consist
previou
report
demonstr
ibv
fuse
late
endosomelysosom
hpi
intracellular
traffick
slower
vsv
result
far
demonstr
ibv
pass
earli
late
endosom
fig
howev
viru
intern
increas
fig
indic
vcp
play
role
postintern
higher
rate
viral
grna
replic
associ
vcp
express
also
detect
rtpcr
use
primer
target
neg
strand
grna
fig
immunofluoresc
show
gfpvcp
confirm
observ
use
inhibitor
cpz
interfer
cme
knock
chc
sirna
specif
block
cme
found
ibv
intern
gene
express
significantli
decreas
evid
determin
import
cme
ibv
entri
wide
hijack
variou
envelop
virus
moreov
import
gtpase
help
snap
vesicl
plasma
membran
determin
ibv
entri
lipid
raft
often
consid
involv
cavm
explain
contradictori
conclus
conduct
systemat
studi
dissect
ibv
entri
process
suscept
cell
line
evid
present
indic
ibv
attach
lipid
raft
induc
actin
depolymer
intern
clathrin
coat
vesicl
via
snap
transport
along
earlyl
endosom
lysosom
final
fuse
late
endosomelysosom
membran
releas
genom
cytoplasm
fig
imag
acquir
confoc
laserscan
microscop
zeiss
repres
imag
shown
scale
temperatur
shift
allow
viru
entri
cell
fix
minpi
incub
alexa
fluor
green
h
stain
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
error
present
panel
b
c
coimag
gfpvcp
vesicl
marker
determin
immunofluores
hpi
gfp
set
control
repres
imag
shown
scale
green
signal
gfp
gfpvcp
red
signal
primer
sequenc
ibv
grna
forward
revers
ibv
grna
forward
revers
forward
revers
dynamin
forward
revers
forward
revers
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
